American Fusion(TM) Inc. (OTC: AMFN), a developer of next-generation fusion energy technologies, has taken significant steps to advance its fusion energy development program. The company announced the appointment of Dr. Robert V. Duncan as an Independent Scientific and Strategic Advisor, bringing over three decades of experience in physics research, national laboratories, and technology commercialization. Dr. Duncan's expertise is expected to guide American Fusion's efforts in validating its Texatron(TM) Fusion Engine(TM) platform.
In parallel, American Fusion has finalized a comprehensive testing protocol for the upcoming validation of its 5MW Pre-Production Texatron(TM) Fusion Engine(TM). The testing framework is designed to support independent scientific evaluation, with calibrated diagnostics, third-party observation, and public reporting planned. This structured approach aims to ensure rigorous and transparent assessment of the fusion engine's performance.
The company continues to expand its intellectual property portfolio, with additional patent applications covering elements of the Texatron(TM) platform. American Fusion recently presented its technology at IEEE ICOPS 2026, engaging with researchers and engineers in the plasma science community. These activities underscore the company's commitment to advancing fusion energy technology.
The appointment of Dr. Duncan and the completion of the testing framework represent critical milestones for American Fusion. Dr. Duncan's background includes leadership roles at national laboratories and universities, which will be instrumental in navigating the scientific and regulatory landscape. The testing protocol emphasizes independent verification, which is crucial for building credibility in the fusion energy sector.
For more information, visit the company's newsroom at https://ibn.fm/AMFN. This development is part of American Fusion's broader strategy to bring fusion energy to commercial viability, addressing the growing demand for clean, sustainable power sources.
